These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3596038)

  • 1. Side effects of BCG vaccination with strain Copenhagen 1331.
    Quast U; Merkle W; Bijok U
    Dev Biol Stand; 1986; 58 ( Pt A)():321-9. PubMed ID: 3596038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Report of clinical testing of BCG vaccine (Strain "1331 Copenhagen") for vaccination of newborns against tuberculosis (author's transl)].
    Nevermann L; Beutnagel H; Schumann K
    Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):481-4. PubMed ID: 780189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part I: Dose finding studies with BCG strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Widmark R
    Dev Biol Stand; 1979; 43():127-32. PubMed ID: 520664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regional suppurative lymphadenitis after BCG vaccination (author's transl)].
    Brehmer W; Falkenberg N; Hussels H; Otto HS; Preussler H; Waldschmidt J
    Dtsch Med Wochenschr; 1977 Sep; 102(35):1251-5. PubMed ID: 902587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BCG vaccination of the newborn infant with the 131 Copenhagen strain].
    Stephan U; Haupt H; Scheier R; Nada A; Grimrath U; Schmitt HG
    Klin Padiatr; 1986; 198(4):295-8. PubMed ID: 3762001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the number of viable units in BCG vaccines.
    Nyerges G; Drinóczy M
    Dev Biol Stand; 1986; 58 ( Pt A)():331-6. PubMed ID: 3297870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigations carried out to ascertain the dose-effect relationship of a BCG vaccine, strain 1331 Copenhagen, in neonates and young infants (author's transl)].
    Lehmann HG; Hennessen W; Engelhardt H; Freudenstein H; Widmark R; Weber-Oldecop H; Oehme J; Siegle-Joos H; Sinios A; Schmidt-Dohna W; Nevermann L; Beutnagel H; Schumann K; Schulz R; Kühl H; Schmöger R
    Zentralbl Bakteriol Orig B; 1978 Mar; 166(2-3):250-63. PubMed ID: 654682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of BCG related lymphadenitis in Malaysian infants.
    Hooi LN; Athiyah SO
    Med J Malaysia; 1994 Dec; 49(4):327-35. PubMed ID: 7674967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
    Szczuka I
    Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Caseation of lymph nodes in infants after intracutaneous vaccination with original French BCG vaccine].
    Zapaśnik-Kobierska MH; Buraczewska M; Rajtar-Leontiew Z
    Pediatr Pol; 1970 Aug; 45(8):923-8. PubMed ID: 4918878
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of antituberculous vaccination in later phases of a successful antituberculous programme.
    Krebs A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):425-31. PubMed ID: 1239469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk factors in the development of complications after BCG vaccination].
    Kozlova AV
    Probl Tuberk; 1984 Aug; (8):15-9. PubMed ID: 6494116
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity.
    Aggarwal A; Dutta AK
    Indian Pediatr; 1995 Jun; 32(6):635-9. PubMed ID: 8613331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the BCG policy in different countries. Children tuberculosis trends comparison between the Federal Republic of Germany and Hungary.
    Lugosi L
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1977; (71):1-19. PubMed ID: 579571
    [No Abstract]   [Full Text] [Related]  

  • 20. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study.
    Dommergues MA; de La Rocque F; Guy C; Lécuyer A; Jacquet A; Guérin N; Fagot JP; Boucherat M; d'Athis P; Cohen R
    Vaccine; 2009 Nov; 27(50):6967-73. PubMed ID: 19800440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.